06 Jan 2022 --- Deerland Probiots & Enzymes is eying a host of opportunities for its probiotic species Bacillus subtilis, whose patent application has just been published.It includes Deerland’s strain DE111 and seeks its use for supplements and functional foods, beverages claiming anti-fungal and anti-microbial properties that exert health benefits of gastrointestinal regularity, immune support and balancing of the microbiome.